Abstract Background and Aims Residual leaks are not infrequent after left atrial appendage
occlusion. However, there is still uncertainty regarding their prognostic implications. The aim …

Patients with atrial fibrillation (AF) experiencing ischemic stroke despite oral anticoagulation
(OAC), ie, breakthrough strokes, are not uncommon, and represent an important clinical …

Aims No studies have compared Watchman 2.5 (W2. 5) with Watchman FLX (FLX) devices
to date. We aimed at comparing the FLX with W2. 5 devices with respect to clinical …

Background: Pericardial effusion (PE) is a potential complication of transcatheter left atrial
appendage occlusion. The objective of this study was to investigate the incidence …

Background When performing transcatheter left atrial appendage (LAA) closure, peridevice
leaks and device-related thrombus (DRT) have been associated with worse clinical …

Background Peridevice leak (PDL) is a limitation of left atrial appendage occlusion.
Objectives The aim of this study was to assess the incidence of and outcomes associated …

Background The benefit related to the use of preprocedural computed tomography
angiography (CCTA) on top of periprocedural echocardiography to plan percutaneous left …

Background Device-related thrombus (DRT) following left atrial appendage occlusion
(LAAO) can lead to adverse clinical outcomes. DRT rates and outcomes from randomized …

Percutaneous left atrial appendage (LAA) closure (LAAC) prevents thromboembolisms in
patients with atrial fibrillation. However, residual LAA patency after LAAC has been …

Aims Atrial fibrillation (AF) and chronic kidney disease (CKD) often coexist and share an
increased risk of thrombo-embolism (TE). CKD concomitantly predisposes towards a pro …